Otros idiomas InhaleRx Limited

Acciones

IRX

AU0000179475

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:31 06/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,04 ^AUD	+2,56 %		0,00 %	+37,93 %

14/02	InhaleRx Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI
2023	InhaleRX completa el ensayo de fase uno de su dispositivo analgésico	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	28/03
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
InhaleRx to Focus on Breakthrough Cancer Pain for Phase 2 Trial of Cannabinoid Analgesic	10/01
InhaleRx Secures Nearly AU$550,000 R&D tax Incentive Prepayment	21/12
InhaleRX Completes Phase One Trial for Pain Medication Device	04/12
InhaleRx Files Ethics Application for Panic Disorder Trial	18/10/23
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23
InhaleRx Limited Announces Change of Registered Office Address	03/08/23
InhaleRx Limited Announces Executive Changes	03/08/23
InhaleRx Completes First Cohort of Phase One Clinical Trial	14/06/23
Australian Shares Retreat Anew on Rate Hike, Slower-than-Expected GDP Growth	07/06/23
InhaleRx Doses First Individuals for Phase One Trial of Inhalable Pain Medication	07/06/23
InhaleRx Limited Auditor Raises 'Going Concern' Doubt	30/03/23
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	26/02/23
InhaleRx Hires Contract Research Organization for Upcoming Clinical Trials	22/12/22
Inhalerx Limited Announces Fda Pre-Ind Application Update	11/12/22
InhaleRx Limited Announces Board and Management Changes	27/09/22
InhaleRx Limited Announces the Appointment of Darryl Davies as Chief Executive Officer	27/09/22
InhaleRx Raises $810,000 From Share Placement	19/09/22
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas InhaleRx Limited

Acciones

IRX

AU0000179475

Otros idiomas

Filtros